Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis is a research paper published in Proceedings of the National Academy of Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 57 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01 DK113984
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01 DK119968
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: P30 DK045735
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R03 DK124743
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01 DK129552
Novo Nordisk Fonden
Grant: NNF18OC0054504
Merck
Grant: MISP 59622
NIDDK NIH HHS
Grant: P30 DK036836
NIDDK NIH HHS
Grant: R01 DK135645
Novo Nordisk Fonden
Grant: NNF19OC0057503
NCATS NIH HHS
Grant: UL1 TR001863
NIBIB NIH HHS
Grant: T32 EB001026
NCI NIH HHS
Grant: R01 CA124414
NIDDK NIH HHS
Grant: P30 DK034989
National Institutes of Health
Grant: 3R01DK129552-04S1
Deciphering Epithelial Signals in the Liver to Drive Inflammation and Fibrosis
National Institutes of Health
Grant: 5R01DK119968-02
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
National Institutes of Health
Grant: 5P30DK034989-22
Pilot and Feasibility Program
National Institutes of Health
Grant: 5P30DK045735-28
Yale Diabetes Research Center
National Institutes of Health
Grant: 5R01DK113984-04
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
Novo Nordisk Foundation
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1R03DK124743-01A1
Hepatocyte Hippo Signaling Drives Inflammation in Liver Injury and Regeneration
FWCI
9.97
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals